๐—ก๐—ฒ๐˜„๐˜€ ๐—ฆ๐˜‚๐—บ๐—บ๐—ฎ๐—ฟ๐˜†
โ€ข Lupin Limited has received tentative approval from the US FDA for its generic equivalent of Invokana Tablets, 100 mg and 300 mg.
โ€ข The product will be manufactured at Lupin's Pithampur facility in India.
โ€ข Canagliflozin Tablets had estimated annual sales of $561 million in the US.